Travere Therapeutics, Inc. TVTX Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s common stock?
- Travere Therapeutics, Inc. (TVTX) reported common stock of $9K in Q1 2026.
- How has Travere Therapeutics, Inc.'s common stock changed year-over-year?
- Travere Therapeutics, Inc.'s common stock decreased by 0.0% year-over-year, from $9K to $9K.
- What is the long-term trend for Travere Therapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s common stock has grown at a 12.5% compound annual growth rate (CAGR), from $5K to $9K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).